Researchers found “no clinically meaningful differences” in efficacy and safety between the biosimilar epoetin alfa-epbx and epoetin alfa.
Natasha Persaud is digital content editor for Renal & Urology News, part of the Medical Communications Group of Haymarket Media. She holds a BA in English from Barnard College.
All articles by Natasha Persaud
The risk for premature death increased by 62% and 42% for stage 3 CKD patients with vitamin D deficiency and elevated parathyroid hormone levels, respectively.